Tech Company Financing Transactions
ViaNautis Funding Round
ViaNautis secured a $25 million funding round on 11/13/2023. Investors included 4BIO Capital, BGF Ventures and UCB Ventures.
Transaction Overview
Company Name
Announced On
11/13/2023
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors
4BIO Capital (Lead Investor)
BGF Ventures (Lead Investor)
UCB Ventures (Lead Investor)
private investors (Eli Lilly)
Proceeds Purpose
The company intends to use the funds to accelerate the development of products using the polyNaut® platform, expand the scientific and management teams and establish laboratory facilities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Babraham Research Campus
Cambridge, CB22 3AT
UK
Cambridge, CB22 3AT
UK
Phone
Undisclosed
Website
Email Address
Overview
ViaNautis is at the forefront of developing novel medications capable of crossing biological barriers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Francesca Crawford
Chief Technical Officer
Denis Cecchin
Co-Founder
Giuseppe Battaglia
Browse more venture capital transactions:
Prev: 11/13/2023: Ray Therapeutics venture capital transaction
Next: 11/13/2023: Imprint venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs